S159 Survival Analysis of Early Onset Pancreatic Cancer: A SEER study (2016-2021)
Sheena Bhushan(Northeast Georgia Medical Center), Oluseyi Abidoye(Mayo Clinic), Jaskaranpreet Kaur(University of South Alabama Medical Center), Abijha Boban(Northeast Georgia Medical Center)
Cited by 0
Related Papers
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
|European Journal of Cancer|2024|47
Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer
|Cells|2025|19
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
|The Oncologist|2024|10